Fresh Recalls

Clindamycin Injection USP in 5% Dextrose: recall status

⚠ Recalls found. Clindamycin Injection USP in 5% Dextrose is named in 4 official recalls in our current data:

Brand
Baxter Healthcare

Recalls naming this model

FDA Class II · Drug · September 9, 2026

Clindamycin Injection USP in 5% Dextrose recall — Baxter Healthcare Corporation

CGMP Deviations

Company / brand: Baxter Healthcare recalls

Affected product: Clindamycin Injection USP in 5% Dextrose recall status

Official ID D-0808-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Clindamycin Injection USP in 5% Dextrose recall — Baxter Healthcare Corporation

CGMP Deviations

Company / brand: Baxter Healthcare recalls

Affected product: Clindamycin Injection USP in 5% Dextrose recall status

Official ID D-0815-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Clindamycin Injection USP in 5% Dextrose recall — Baxter Healthcare Corporation

CGMP Deviations

Company / brand: Baxter Healthcare recalls

Affected product: Clindamycin Injection USP in 5% Dextrose recall status

Official ID D-0817-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Clindamycin Injection USP in 5% Dextrose recall — Baxter Healthcare Corporation

CGMP Deviations

Company / brand: Baxter Healthcare recalls

Affected product: Clindamycin Injection USP in 5% Dextrose recall status

Official ID D-0818-2026 · Official record ↗

See all Baxter Healthcare recalls →

Verify with the official sources:

Found something wrong or missing? Report a data error.

Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 12:00 PM UTC.